Immunogenicity Testing, Biotech Reagents, Contract Work

ANP Technologies, Inc. specializes in a diverse range of products and services tailored for the biodefense, pharmaceutical, life sciences, immunogenicity, and food safety sectors. One of their key offerings is the NIDS® rapid and handheld assays, which are utilized by the U.S. military and first responders for the detection of biological and chemical threats. Additionally, ANP has developed a library of patented polymers that enable the nanoencapsulation of both small and large molecule drugs, enhancing their pharmacokinetics, reducing toxicity, and improving therapeutic efficacy and stability. This innovative approach has led to multiple drugs advancing to the Investigational New Drug (IND) stage or beyond.

In the realm of immunogenicity, ANP Technologies provides top-tier testing products, including the ANPEG-1 IgM antibody and comprehensive PEG ELISA Kits, along with customizable kits for various applications. Their life sciences portfolio features a wide array of products such as ANPEG Antibody, Streptavidin & Neutravidin ELISA Plates, and various protein labeling and extraction kits. ANP's commitment to quality and customer support is evident, as they actively assist clients in troubleshooting and optimizing their testing processes, ensuring that their technologies meet the high standards required in critical industries.

United States

Founded in 2002, ANP Technologies, Inc. is an emerging nanobiotechnology company with a major focus on design, development, and marketing of innovative technologies. ANP Technologies, Inc. is a nanobiotechnology company with cutting-edge technology platforms focused on:

• Specialty CRO for biological drug R&D 

• Biodefense and homeland security

• Home/point-of-care diagnostic systems 

• Nanoencapsulation and targeted drug delivery and therapy

ANP Technologies

Company Details